Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MDR1/P-gp and VEGF Synergistically Enhance the Invasion of Hep-2 Cells with Multidrug Resistance Induced by Taxol

MDR1/P-gp and VEGF Synergistically Enhance the Invasion of Hep-2 Cells with Multidrug Resistance... MDR1/P-pg may be a risk predictor for the invasion of laryngeal cancer. MDR1 knock down and VEGFR-2 inhibitor may be two promising treatment regiments for advanced laryngeal carcinoma patients with MDR and invasion/metastasis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

MDR1/P-gp and VEGF Synergistically Enhance the Invasion of Hep-2 Cells with Multidrug Resistance Induced by Taxol

Loading next page...
 
/lp/springer-journals/mdr1-p-gp-and-vegf-synergistically-enhance-the-invasion-of-hep-2-cells-HmLr542RfR

References (37)

Publisher
Springer Journals
Copyright
Copyright © 2009 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgery ; Oncology ; Surgical Oncology
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/s10434-009-0395-7
pmid
19247716
Publisher site
See Article on Publisher Site

Abstract

MDR1/P-pg may be a risk predictor for the invasion of laryngeal cancer. MDR1 knock down and VEGFR-2 inhibitor may be two promising treatment regiments for advanced laryngeal carcinoma patients with MDR and invasion/metastasis.

Journal

Annals of Surgical OncologySpringer Journals

Published: Feb 27, 2009

There are no references for this article.